The HCPLive conference coverage page features articles, videos, and expert-led live coverage from major medical meetings throughout the year.
September 8th 2022, 8:11pm
Large numbers of vitiligo patients around the world have reported differing outcomes, with darker skin types expressing the more significant severity, according to new findings.
September 8th 2022, 7:45pm
Research presented at EADV 2022 sees positive outcomes with the targeted therapy for patients of varied backgrounds with vitiligo.
September 8th 2022, 4:02pm
Novel insights into the risk-benefit profile of nintedanib in children and adolescents with fibrosing interstitial lung disease (ILD) were provided by late-breaking data presented at ERS 2022 regarding the InPedILD clinical trial.
September 7th 2022, 6:00pm
These data support web-based self-management for individuals with COPD with an objective, clinically relevant, short-term increase in physical activity levels compared to usual care.
September 6th 2022, 9:00pm
“From this study it makes sense that the (icenticaftor) 300mg dose has a benefit-risk profile to further study the clinical benefits,” Dr. Frits Franssen, lead investigator, said at ERS Congress 2022.
August 31st 2022, 1:00pm
Temperatures changes between summer and the rest of the year correlated with the magnitude of decrease in renal function during summer.
August 30th 2022, 4:00pm
Increased risk of AF by fish oil supplement was found to be prominent in low risk participants with healthy lifestyles.
August 29th 2022, 10:00pm
Full-dose anticoagulation, but not clopidogrel, reduced thrombotic complications in critically-ill patients with COVID-19.
August 29th 2022, 8:00pm
Digital screening more than doubled the detection rate of treatment-relevant AF in both phases of eBRAVE-AF trial.
August 28th 2022, 1:00pm
Targeting a mean arterial blood pressure of 77 mm Hg or 63 mm Hg was not associated with significantly different percentages of patients dying or having severe disability or coma.